Angiogenesis as a potential biomarker in prostate cancer chemoprevention trials
- 1 April 2001
- Vol. 57 (4) , 143-147
- https://doi.org/10.1016/s0090-4295(00)00961-4
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Mutational Spectra of PTEN/MMAC1 Gene: a Tumor Suppressor With Lipid Phosphatase ActivityJNCI Journal of the National Cancer Institute, 1999
- Prognostic value of immunohistochemical expression of the c-erbB-2 oncoprotein in metastasic prostate cancerInternational Journal of Cancer, 1999
- Molecular Biology of Progression of Prostate CancerEuropean Urology, 1999
- Tumour suppressor genes in prostate cancerSeminars in Cancer Biology, 1997
- Molecular advances in prostate cancerCurrent Opinion in Oncology, 1997
- Comparison ofras activation in prostate carcinoma in Japanese and American menThe Prostate, 1997
- Platelet-derived growth factor A and B chains and the α and β receptors in prostatic intraepithelial neoplasiaThe Prostate, 1996
- Allelic loss of the retinoblastoma gene in primary human prostatic adenocarcinomasThe Prostate, 1995
- Early detection of prostate cancerHuman Pathology, 1992
- Clinical Evidence for and Implications of the Multistep Development of Prostate CancerJournal of Urology, 1990